An economic model comparing tolerability of ziprasidone, olanzapine, risperidone, and haloperidol

被引：0
|
作者：
Russell, JM [1 ]
Mackell, JA [1 ]
机构：
[1] Univ Texas, Med Branch, Galveston, TX 77550 USA
来源：
SCHIZOPHRENIA RESEARCH | 2003年 / 60卷 / 01期
关键词：
D O I：
10.1016/S0920-9964(03)80345-6
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：343 / 343
页数：1
相关论文
共 50 条
  • [31] The tolerability of intramuscular ziprasidone and haloperidol treatment and the transition to oral therapy
    Daniel, DG
    Zimbroff, DL
    Swift, RH
    Harrigan, EP
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2004, 19 (01) : 9 - 15
  • [32] Haloperidol, Olanzapine, and Risperidone Induce Morphological Changes in an In Vitro Model of Human Hippocampal Neurogenesis
    Jezso, Balint
    Kalman, Sara
    Farkas, Kiara Gitta
    Hathy, Edit
    Vincze, Katalin
    Kovacs-Schoblocher, Dzsenifer
    Lilienberg, Julianna
    Tordai, Csongor
    Nemoda, Zsofia
    Homolya, Laszlo
    Apati, Agota
    Rethelyi, Janos M.
    BIOMOLECULES, 2024, 14 (06)
  • [33] Neurocognitive effectiveness of quetiapine, olanzapine, risperidone, and ziprasidone: A pragmatic, randomized trial
    Johnsen, E.
    Jorgensen, H. A.
    Kroken, R. A.
    Loberg, E. -M.
    EUROPEAN PSYCHIATRY, 2013, 28 (03) : 174 - 184
  • [34] Schizophrenia: risperidone and olanzapine increase time to discontinuation compared with quetiapine and ziprasidone
    Carpenter, William T.
    EVIDENCE-BASED MENTAL HEALTH, 2006, 9 (04) : 106 - 106
  • [35] Intramuscular Midazolam, Olanzapine, Ziprasidone, or Haloperidol for Treating Acute Agitation Reply
    Klein, Lauren R.
    Driver, Brian E.
    Martel, Marc L.
    Miner, James R.
    Cole, Jon B.
    ANNALS OF EMERGENCY MEDICINE, 2019, 73 (04) : 423 - 424
  • [36] Antipsychotic Treatment Effectiveness in First Episode of Psychosis: PAFIP 3-Year Follow-Up Randomized Clinical Trials Comparing Haloperidol, Olanzapine, Risperidone, Aripiprazole, Quetiapine, and Ziprasidone
    Gomez-Revuelta, Marcos
    Maria Pelayo-Teran, Jose
    Juncal-Ruiz, Maria
    Vazquez-Bourgon, Javier
    Suarez-Pinilla, Paula
    Romero-Jimenez, Rodrigo
    Setien Suero, Esther
    Ayesa-Arriola, Rosa
    Crespo-Facorro, Benedicto
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2020, 23 (04): : 217 - 229
  • [37] Oral risperidone, olanzapine and quetiapine versus haloperidol in psychotic agitation
    Villari, Vincenzo
    Rocca, Paola
    Fonzo, Valeria
    Montemagni, Cristiana
    Pandullo, Pasquale
    Bogetto, Filippo
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2008, 32 (02): : 405 - 413
  • [38] The Prevalence of Metabolic Syndrome of Patients on Treatment with Haloperidol and Risperidone or Olanzapine
    Suresh, Velumani
    Lakhani, J. D.
    Shah, Rakesh
    Kataria, Lakhan
    Balaraman, Ramachandran
    JOURNAL OF PHARMACEUTICAL RESEARCH INTERNATIONAL, 2021, 33 (44A) : 320 - 327
  • [39] Onset and characteristics of Akathisia in patients treated with olanzapine, risperidone and haloperidol
    Sabljic, V
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S409 - S409
  • [40] Ethnicity and schizophrenia medication choice: haloperidol risperidone, or olanzapine.
    Opolka, JL
    Rascati, KL
    Brown, CM
    Gibson, PJ
    PHARMACOTHERAPY, 2003, 23 (03): : 412 - 412
12345